Professional Documents
Culture Documents
PRODUCT DESCRIPTION
Instructions:
a) All documents must be completely and clearly filled in, signed & dated by the
concerned personnel.
b) Any correction(s) or changes must only be crossed with a line (exp. corllection
correction) and initiated and dated. Overwriting and Use of Blanco / whitener are
prohibited.
c) Any observation(s) or suggestion(s) at any stage must be written overleaf.
d) All the relevant documents (s) associated with the production of the batch should be
attached with this BMR.
e) Copying of this document in whole or part is strictly prohibited.
Page 1 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Note:
In case of potency adjustment of active ingredient, the quantity of diluents should be adjusted according to the target wt.
S# Water For Injection Unit Quantity Per Batch Quantity Issued Q.C. No
Batch No:
1 Mfg. Date:
Exp. Date:
Page 2 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Note:
In case of potency adjustment of active ingredient, the quantity of diluents should be adjusted according to the target wt.
S# Water For Injection Unit Quantity Per Batch Quantity Issued Q.C. No
Batch No:
1 Mfg. Date:
Exp. Date:
Page 3 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Nos
2 Label
Nos
3 Leaflet
Nos
4 F/O Seal (Green)
Nos
5 Rubber Stopper
Nos
6 Glass Vials 10cc
Nos
7 Master Carton
Nos
8 Pasting Tape
Page 4 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Nos
2 Label
Nos
3 Leaflet
Nos
4 F/O Seal (Green)
Nos
5 Rubber Stopper
Nos
6 Glass Vials 10cc
Nos
7 Master Carton
Nos
8 Pasting Tape
Page 5 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
R.O Water for washing purpose is sent to Q.C Department for testing along with request for
analysis.
Sample
100 ml
06 Calcium - ve
07 Magnesium - ve
Remarks:
Released For Washing Rejected
Page 6 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
R.O Water for washing purpose is sent to Q.C Department for testing along with request for
analysis.
Sample
100 ml
06 Calcium - ve
07 Magnesium - ve
Remarks:
Released For Washing Rejected
Page 7 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Distilled Water for washing purpose is sent to Q.C Department for testing along with request
for analysis.
Sample
100 ml
Remarks:
Released For Washing Rejected
Page 8 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Distilled Water for washing purpose is sent to Q.C Department for testing along with request
for analysis.
Sample
100 ml
Remarks:
Released For Washing Rejected
Page 9 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Line Clearance
Equipment / Machine (washing machine, S.S trays, filters, sink etc.) to be used for washing are clean
and clear from the remains of previous product.
0 0
In the water storage tank temperature should be between (70 C to 80 C).
Page 10 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Page 11 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
o
Set the temperature controller to the 230 C
Turn “ON” the dryer and view for normal setting.
Turn the dryer ”OFF” after one and half hour by
noting the time and temperature.
Disconnect the “POWER SUPPLY” and leave the vials in the
dryer to be cooled down to the room temperature.
Sterilization cycle Sterilization cycle Total Time
Start Time Complete Time
Page 12 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Page 13 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Page 14 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Remarks:
Area Released For Filling Rejected
Page 15 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Remarks:
Area Released For Filling Rejected
Page 16 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
1. Send request for analysis to Quality Control Department for Physical, Chemical, Sterility and
Pyrogen test of Vials.
2. After release received from Quality Control Department proceed for filling.
Specification
Sample Size Collection Date Collected By Sent to Qc QC No
Reference
USP
7 ASSAY 90 – 115 %
Remarks:
Released For Filling Rejected
Page 17 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
1. Send request for analysis to Quality Control Department for Physical, Chemical, Sterility and
Pyrogen test of Vials.
2. After release received from Quality Control Department proceed for filling.
Specification
Sample Size Collection Date Collected By Sent to Qc QC No
Reference
USP
7 ASSAY 90 – 115 %
Remarks:
Released For Filling Rejected
Page 18 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Page 19 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Page 20 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Remarks:
Area is Cleared Rejected
Page 21 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Remarks:
Area is Cleared Rejected
Page 22 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
1. Send request for analysis to Quality Control Department for Physical, Chemical, Sterility and
Pyrogen test of Filled Vials.
2. After release received from Quality Control Department proceed for Labelling.
Specification
Sample Size Collection Date Collected By Sent to Qc QC No
Reference
USP
8 ASSAY 90 – 115 %
Remarks:
Released For Labelling Rejected
Page 23 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
1. Send request for analysis to Quality Control Department for Physical, Chemical, Sterility and
Pyrogen test of Filled Vials.
2. After release received from Quality Control Department proceed for Labelling.
Specification
Sample Size Collection Date Collected By Sent to Qc QC No
Reference
USP
8 ASSAY 90 – 115 %
Remarks:
Released For Labelling Rejected
Page 24 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Containers for storage of vials, rejected vials, checked vials are properly identified and identification
slip properly pasted.
Ensure that Temperature and RH of the area and record in T/RH monitoring sheet.
Page 25 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
_____________________________________
Total Number of Vials Rejected during Optical
Checking.
_____________________________________
____________________________________________
PACKAGING
Ensure that the printing section is clean and clear from the remains of previous product.
Containers for printed and unprinted packaging components are properly identified and identification
slip properly pasted.
Page 26 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Product Over-Printing
Matter to be printed on Label & U/C for Injection
Product: Axon 1 g Injection
Batch No.:
Item: Label / Unit Carton Mfg. Date:
Quantity: Exp. Date:
Details on Ampoule of WFI
Production Officer:
WFI Batch No.:
WFI Mfg Date: Pre Printed Ampoules
Q.A. Officer:
WFI Exp. Date:
Labels
Page 27 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Product to be packed is properly identified and approval has been taken from
the Q. A. Department.
Conveyer belt is clean and cleared from the remains of previous product.
All packaging components have been verified and cross checked as per the
quantity mentioned in the packing order.
Related documents of the product to be packed are available on the belt.
Labels
Page 28 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Product Over-Printing
Product: Axon 1g Injection
Batch No.:
Commercial Mfg. Date:
Packing: P/S
Exp. Date:
Belt Incharge: WFI Batch No.
Production Officer Available: Pre-Printed
WFI Mfg. Date: Ampoules
Yes No
WFI Expiry Date:
Equipment / Operation clearance
Previous Product: Clearance Granted
Batch No.:
Ensure that there should not
be any remains of the previous batch. ____________ _____________ __________
Q.A. Officer Time Date
Date:
Time:
Batch No.
Label
Mfg. Date
Exp. Date
Batch No.
Unit Carton
Mfg. Date
Exp. Date
M.R.P. Rs.
Leaflet Available (Y/N)
Units Packed
Master Carton
Batch No.
Mfg. Date
Exp. Date
QC Retains Sample 08 Samples Taken By:
Packing Pharmacist
QAI
Page 29 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Quantity Transfer
Date Commercial / PS No of M/C Loose Packs Total Packs
(a) (b) (a+b)
Page 30 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Quantity Transfer
Date Commercial / PS No of M/C Loose Packs Total Packs
(a) (b) (a+b)
Page 31 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
1. R. Stoppers No. 3%
Supplementary Materials:
_________________________________________________________________________
_________________________________________________________________________
Step 19 Disposal / Destruction of Excess / Rejected Material
Page 32 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
1. R. Stoppers No. 3%
Supplementary Materials:
_________________________________________________________________________
_________________________________________________________________________
Step 19 Disposal / Destruction of Excess / Rejected Material
Page 33 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
OPTICAL CHECKING:
Objective Fill Weight of Vials (D): _________________________________________
PACKING:
Packing (Sales)
Total Qty. Packed In-process QC Sample (J) Total Unit
(I) (G+H) (I+J)
Packing (P/S)
Total Qty. Packed In-process QA Sample Total Unit
(K) (L) (K+L)
Page 34 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Sales
Actual yield Actual Yield x 100
Theoretical Yield
P/S
Actual yield Actual Yield x 100
Theoretical Yield
Total Yield % Sale Yield + PS Yield
Limit: + 3%
Remarks: ---------------------------------------------------------------------------------------------------------
Director Operation
Page 35 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Page 36 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
1. Send request for analysis to Quality Control Department for Physical, Chemical, Sterility and
Pyrogen test of Final Product.
2. After release received from Quality Control Department proceed for Marketing.
Specification
Sample Size Collection Date Collected By Sent to Qc QC No
Reference
USP
8 ASSAY 90 – 115 %
Remarks:
Released For Marketing Rejected
Page 37 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
1. Send request for analysis to Quality Control Department for Physical, Chemical, Sterility and
Pyrogen test of Final Product.
2. After release received from Quality Control Department proceed for Marketing.
Specification
Sample Size Collection Date Collected By Sent to Qc QC No
Reference
USP
8 ASSAY 90 – 115 %
Remarks:
Released For Marketing Rejected
Page 38 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Remarks:_____________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
Page 39 of 40
WNSFEILD PHARMACEUTICALS
DOCUMENT #: ISSUED STATUS: ISSUED On:
WNS/QA/BMR/ 1 01-03-2017
INJ/001
QUALITY ASSURANCE DEPARTMENT
Remarks:_____________________________________________________________
________________________________________________________________________
________________________________________________________________________
Page 40 of 40